TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biocell AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
37,347 |
| Financial expenses |
1
|
1,897
|
2 |
| Earnings before taxes |
107
|
1,128
|
10,251 |
| EBITDA |
-725
|
-627
|
4,867 |
| Total assets |
14,560
|
14,727
|
15,819 |
| Current assets |
8,205
|
10,245
|
11,243 |
| Current liabilities |
1,961
|
2,804
|
4,289 |
| Equity capital |
12,599
|
11,923
|
11,530 |
| - share capital |
1,013
|
946
|
975 |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.5%
|
81.0%
|
72.9% |
| Turnover per employee | 37,347 | ||
| Profit as a percentage of turnover | 27.4% | ||
| Return on assets (ROA) |
0.7%
|
20.5%
|
64.8% |
| Current ratio |
418.4%
|
365.4%
|
262.1% |
| Return on equity (ROE) |
0.8%
|
9.5%
|
88.9% |
| Change turnover |
0
|
-36,225
|
2,397 |
| Change turnover % |
-100%
|
7% | |
| Chg. No. of employees |
0
|
-1
|
1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.